SE9804614L - - Google Patents

Info

Publication number
SE9804614L
SE9804614L SE9804614A SE9804614A SE9804614L SE 9804614 L SE9804614 L SE 9804614L SE 9804614 A SE9804614 A SE 9804614A SE 9804614 A SE9804614 A SE 9804614A SE 9804614 L SE9804614 L SE 9804614L
Authority
SE
Sweden
Prior art keywords
relates
peptides
amino acids
food
inflammations
Prior art date
Application number
SE9804614A
Other languages
English (en)
Other versions
SE9804614D0 (sv
SE9804614A0 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE9804614L publication Critical patent/SE9804614L/xx
Priority claimed from SE9802441A external-priority patent/SE9802441D0/xx
Priority claimed from SE9802562A external-priority patent/SE9802562D0/xx
Application filed filed Critical
Priority to SE9804614A priority Critical patent/SE9804614A0/sv
Publication of SE9804614D0 publication Critical patent/SE9804614D0/xx
Priority to JP2000558131A priority patent/JP4488622B2/ja
Priority to ES99935241T priority patent/ES2299253T3/es
Priority to PCT/SE1999/001230 priority patent/WO2000001730A1/fr
Priority to AU50760/99A priority patent/AU752640B2/en
Priority to DE69937798T priority patent/DE69937798T2/de
Priority to EP99935241A priority patent/EP1095061B1/fr
Priority to DK99935241T priority patent/DK1095061T3/da
Priority to PT99935241T priority patent/PT1095061E/pt
Priority to AT99935241T priority patent/ATE381578T1/de
Priority to CA2333306A priority patent/CA2333306C/fr
Priority to NZ509622A priority patent/NZ509622A/en
Priority to US09/743,107 priority patent/US7253143B1/en
Publication of SE9804614A0 publication Critical patent/SE9804614A0/sv
Priority to HK01107436A priority patent/HK1036630A1/xx
Priority to US11/819,901 priority patent/US7803757B2/en
Priority to CY20081100292T priority patent/CY1108049T1/el
Priority to JP2009283513A priority patent/JP2010090162A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23L1/3053—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SE9804614A 1998-07-06 1998-12-29 New peptides and use thereof SE9804614A0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9804614A SE9804614A0 (en) 1998-07-06 1998-12-29 New peptides and use thereof
AT99935241T ATE381578T1 (de) 1998-07-06 1999-07-06 Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung
CA2333306A CA2333306C (fr) 1998-07-06 1999-07-06 Peptides reposant sur la sequence de la lactoferrine humaine et leur utilisation
ES99935241T ES2299253T3 (es) 1998-07-06 1999-07-06 Peptidos basados en la secuencia de la lactoferrina humana y sus usos,.
US09/743,107 US7253143B1 (en) 1998-07-06 1999-07-06 Peptides based on the sequence of human lactoferrin and their use
DE69937798T DE69937798T2 (de) 1998-07-06 1999-07-06 Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung
NZ509622A NZ509622A (en) 1998-07-06 1999-07-06 Peptides based on the sequence of human lactoferrin and their use
PCT/SE1999/001230 WO2000001730A1 (fr) 1998-07-06 1999-07-06 Peptides reposant sur la sequence de la lactoferrine humaine et leur utilisation
AU50760/99A AU752640B2 (en) 1998-07-06 1999-07-06 Peptides based on the sequence of human lactoferrin and their use
JP2000558131A JP4488622B2 (ja) 1998-07-06 1999-07-06 人ラクトフェリンの配列に基づくペプチドおよびその使用
EP99935241A EP1095061B1 (fr) 1998-07-06 1999-07-06 Peptides bases sur la sequence de la lactoferrine humaine et leur utilisation
DK99935241T DK1095061T3 (da) 1998-07-06 1999-07-06 Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
PT99935241T PT1095061E (pt) 1998-07-06 1999-07-06 Péptidos baseados na sequência da lactoferrina humana e sua utilização
HK01107436A HK1036630A1 (en) 1998-07-06 2001-10-24 Peptides based on the sequence of human lactoferrin and their use
US11/819,901 US7803757B2 (en) 1998-07-06 2007-06-29 Peptides based on the sequence of human lactoferrin and their use
CY20081100292T CY1108049T1 (el) 1998-07-06 2008-03-14 Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
JP2009283513A JP2010090162A (ja) 1998-07-06 2009-12-14 人ラクトフェリンの配列に基づくペプチドおよびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802441A SE9802441D0 (sv) 1998-07-06 1998-07-06 New peptides and use thereof
SE9802562A SE9802562D0 (sv) 1998-07-17 1998-07-17 New peptides and use thereof
SE9804614A SE9804614A0 (en) 1998-07-06 1998-12-29 New peptides and use thereof

Publications (3)

Publication Number Publication Date
SE9804614L true SE9804614L (fr) 1900-01-01
SE9804614D0 SE9804614D0 (sv) 1998-12-29
SE9804614A0 SE9804614A0 (en) 2000-01-07

Family

ID=27355931

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804614A SE9804614A0 (en) 1998-07-06 1998-12-29 New peptides and use thereof

Country Status (15)

Country Link
US (2) US7253143B1 (fr)
EP (1) EP1095061B1 (fr)
JP (2) JP4488622B2 (fr)
AT (1) ATE381578T1 (fr)
AU (1) AU752640B2 (fr)
CA (1) CA2333306C (fr)
CY (1) CY1108049T1 (fr)
DE (1) DE69937798T2 (fr)
DK (1) DK1095061T3 (fr)
ES (1) ES2299253T3 (fr)
HK (1) HK1036630A1 (fr)
NZ (1) NZ509622A (fr)
PT (1) PT1095061E (fr)
SE (1) SE9804614A0 (fr)
WO (1) WO2000001730A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
EP1737884B1 (fr) 2004-03-19 2016-10-19 The University Of Queensland Alpha-mimetiques helicoidales, leurs utilisations et leurs procedes de production
WO2006047744A2 (fr) 2004-10-26 2006-05-04 Agennix Incorporated Compositions de peptides en rapport avec la lactoferrine et utilisations
ATE501169T1 (de) 2005-12-30 2011-03-15 Evonik Roehm Gmbh Lactoferrin-peptide, geeignet als in die zelle eindringende peptide
US7960339B2 (en) * 2006-07-10 2011-06-14 Österreichische Akademie der Wissenschaften Antimicrobial peptides
AU2008206256A1 (en) 2007-01-16 2008-07-24 Rutgers, The State University Of New Jersey Natural polypeptides for oral health care
EP2050461A1 (fr) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides basées sur la séquence de lactoferrin humain et leur utilisation
EP2060586A1 (fr) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB Nouveaux peptides synthétiques d'arginine substitué et leur utilisation
AU2009257631B2 (en) 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
RU2501566C2 (ru) 2009-01-13 2013-12-20 Пергамум АБ Новые фармацевтические композиции
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2011063366A1 (fr) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Peptides cycliques spécifiques du récepteur de la mélanocortine-1
CA2781405A1 (fr) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Peptides lineaires specifiques du recepteur de la melanocortine-1
JP5177901B2 (ja) * 2009-12-02 2013-04-10 株式会社明治 栄養組成物
CN101891885B (zh) * 2010-08-18 2012-12-12 中国科学院长春应用化学研究所 聚丝氨酸酯及其制备方法
EP2481751A1 (fr) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Homme peptides dérivés de lactoferrine
WO2013062479A1 (fr) * 2011-10-28 2013-05-02 Glycorex Transplantation Ab Procédé pour l'élimination extracorporelle d'un ou de plusieurs constituants à partir du sang
JP5763024B2 (ja) * 2012-09-07 2015-08-12 株式会社明治 栄養組成物
WO2014174517A1 (fr) * 2013-04-25 2014-10-30 Carmel-Haifa University Economic Corp. Peptides anti-inflammatoires synthétiques et leur utilisation
JP6912887B2 (ja) 2013-12-12 2021-08-04 ライフ テクノロジーズ コーポレーション トランスフェクションの強化のための膜透過性ペプチドならびにそれらを使用する組成物及び方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
EP0629347B1 (fr) 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Agent antibacterien et traitement d'articles au moyen de cet agent
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3738042B2 (ja) 1994-05-17 2006-01-25 森永乳業株式会社 非経口用抗腫瘍剤
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JP3506274B2 (ja) 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP3830179B2 (ja) * 1995-07-31 2006-10-04 森永乳業株式会社 抗寄生虫剤
JPH09165342A (ja) 1995-12-14 1997-06-24 Morinaga Milk Ind Co Ltd 抗真菌剤
WO1998006425A1 (fr) * 1996-08-12 1998-02-19 A+ Science Invest Ab Traitement et prevention d'infections, d'inflammations et/ou de tumeurs a l'aide de lactoferrine et/ou de lactoferricine
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof

Also Published As

Publication number Publication date
DE69937798T2 (de) 2009-04-30
HK1036630A1 (en) 2002-01-11
US20080299180A1 (en) 2008-12-04
WO2000001730A1 (fr) 2000-01-13
NZ509622A (en) 2003-05-30
DK1095061T3 (da) 2008-04-21
US7253143B1 (en) 2007-08-07
JP4488622B2 (ja) 2010-06-23
DE69937798D1 (de) 2008-01-31
CY1108049T1 (el) 2012-05-23
CA2333306C (fr) 2011-12-06
PT1095061E (pt) 2008-03-10
EP1095061A1 (fr) 2001-05-02
JP2010090162A (ja) 2010-04-22
SE9804614D0 (sv) 1998-12-29
JP2002519438A (ja) 2002-07-02
ES2299253T3 (es) 2008-05-16
EP1095061B1 (fr) 2007-12-19
US7803757B2 (en) 2010-09-28
SE9804614A0 (en) 2000-01-07
AU5076099A (en) 2000-01-24
AU752640B2 (en) 2002-09-26
ATE381578T1 (de) 2008-01-15
CA2333306A1 (fr) 2000-01-13

Similar Documents

Publication Publication Date Title
SE9804614L (fr)
Niaz et al. Lactoferrin (LF): A natural antimicrobial protein
Nagpal et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update
Mati et al. Dromedary camel milk proteins, a source of peptides having biological activities–A review
Beermann et al. Physiological properties of milk ingredients released by fermentation
Madureira et al. Invited review: physiological properties of bioactive peptides obtained from whey proteins
Floris et al. Antibacterial and antiviral effects of milk proteins and derivatives thereof
Siqueiros-Cendón et al. Immunomodulatory effects of lactoferrin
Expósito et al. Antibacterial activity of peptides and folding variants from milk proteins
Latorre et al. LF immunomodulatory strategies: mastering bacterial endotoxin
Pepe et al. Potential anticarcinogenic peptides from bovine milk
El-Sayed et al. Milk bioactive peptides: antioxidant, antimicrobial and anti-diabetic activities
Pan et al. Biological properties of lactoferrin: an overview
US20090270309A1 (en) Use of lactoferrin fragments and hydrolysates
Jiang et al. Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk
TW201004640A (en) Treatment of inflammatory bowel diseases with mammal beta defensins
Ebrahim et al. Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf)
Nielsen et al. Bioactive milk peptides: an updated comprehensive overview and database
KR20060095899A (ko) 암치료를 위한 약제
Kim et al. Understanding the roles of host defense peptides in immune modulation: from antimicrobial action to potential as adjuvants
Anusha et al. Bioactive peptides from milk
Coccolini et al. Biomedical and nutritional applications of lactoferrin
Jabbari et al. Antimicrobial peptides from milk proteins: a prospectus
Morris et al. Whey proteins and peptides in human health
McCarthy et al. Bioactive peptides from casein and whey proteins

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9804614-7

Format of ref document f/p: F